Mankind Pharma, the maker of Manforce brand condoms and pregnancy test kits, rallied 32% on its debut on the Indian stock exchange, setting the stage for other IPO hopefuls in an otherwise muted public market this year.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
